Not Yet Recruiting PHASE1 INTERVENTIONAL 1-arm
NCT06647277
Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease
An Open-Label Phase I Clinical Trial of Vancomycin Followed by Fecal Microbiota Transplant for the Treatment of Parkinson's Disease
Sponsor: ProgenaBiome
Conditions
Parkinson Disease
Interventions
Fecal Microbiota Transplant
Updated 2 times since 2024 Last updated: Jun 23, 2025 Started: Jul 31, 2026 Primary completion: Dec 31, 2027 Completion: Dec 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE1 trial investigates Parkinson Disease and is currently actively recruiting participants. ProgenaBiome leads this study, which shows 2 recorded versions since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
2 versions recorded-
Jul 2025 — Present [monthly]
Not Yet Recruiting PHASE1
-
Nov 2024 — Jul 2025 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- ProgenaBiome
Data source: ProgenaBiome
For direct contact, visit the study record on ClinicalTrials.gov .